Back
Zevra Therapeutics Vs. Vanda Pharmaceuticals Industry Stock Comparison
Sell
44
ZVRA
Zevra Therapeutics
Last Price:
$8.49
Seasonality Move:
-0.81%
Sell
33
VNDA
Vanda Pharmaceuticals
Last Price:
$4.78
Seasonality Move:
-2.27%
Sell
44
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy, Sell or Hold?
-
The current Zevra Therapeutics [ZVRA] share price is $8.49. The Score for ZVRA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
-
The current Vanda Pharmaceuticals [VNDA] share price is $4.78. The Score for VNDA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
VNDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $8.49The current trend is relatively stagnant and ZVRA is experiencing slight selling pressure.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $4.78The current trend is relatively stagnant and VNDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZVRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 44.11 | Sell |
Chaikin Money Flow: | -999179 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.54 - 9.36) | Sell |
Bollinger Bands (100): | (7.24 - 8.84) | Buy |
VNDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 49.02 | Sell |
Chaikin Money Flow: | 501740 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.67 - 5.03) | Sell |
Bollinger Bands (100): | (4.64 - 5.24) | Sell |
ZVRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.5 | Sell |
20-day SMA: | 8.98 | Sell |
50-day SMA: | 8.69 | Sell |
200-day SMA: | 6.59 | Buy |
8-day EMA: | 8.56 | Sell |
20-day EMA: | 8.74 | Sell |
50-day EMA: | 8.56 | Sell |
200-day EMA: | 7.14 | Buy |
VNDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.65 | Buy |
20-day SMA: | 4.83 | Sell |
50-day SMA: | 4.84 | Sell |
200-day SMA: | 5.02 | Sell |
8-day EMA: | 4.69 | Buy |
20-day EMA: | 4.77 | Buy |
50-day EMA: | 4.85 | Sell |
200-day EMA: | 5 | Sell |
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zevra Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vanda Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |